Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease
Conditions: Graft-versus-host-disease; CMV Intervention: Drug: Letermovir Sponsor: Rabin Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cytomegalovirus | Research